EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Real‐world use of adjunctive perampanel for focal‐onset seizures in Italy: A mirroring clinical practice study of perampanel in adults and adolescents ( AMPA )

Alfredo D'Aniello iD, Anna Teresa Giallonardo iD, Paolo Tinuper iD, Oriano Mecarelli iD, Umberto Aguglia iD, Giovanni Assenza iD, Antonio Gambardella iD, Maria Paola Canevini iD, Renato Scifo iD, Stefano Meletti iD, Valentina De Giorgis iD, Enrica Bonanni iD und 13 weitere

Epilepsia Open · 2025

DOI: 10.1002/epi4.70068 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia Open, 2025. Verfasst von Alfredo D'Aniello und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epilepsy, IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy. Hauptthemen laut MEDLINE: Pyridones, Anticonvulsants, Seizures, Epilepsies, Partial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eisai s.r.l.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The AMPA study (Study 501; NCT04257604) was a multicenter, prospective, 12‐month observational study in Italy that evaluated the effectiveness and safety of adjunctive perampanel in patients with focal‐onset seizures (FOS), with or without focal to bilateral tonic–clonic seizures (FBTCS).

Methods

Patients aged ≥12 years with insufficiently controlled FOS, with or without FBTCS, receiving 1–3 anti‐seizure medications (ASMs) were prescribed adjunctive perampanel per the approved indication. The primary endpoint was the median percent change in total seizure frequency per 28 days from baseline at Month 6. Baseline seizure frequency per 28 days was calculated using seizure diaries and/or medical records of seizures occurring in the 8 weeks prior to the baseline visit while patients were receiving 1–3 ASMs. Treatment‐emergent adverse events (TEAEs), including serious TEAEs, were monitored for up to 12 months.

Results

Of the 240 patients enrolled in the study, 234 were included in the Full and Safety Analysis Sets. Median age (minimum, maximum) was 36.0 years (12, 84) and 51.3% ( n = 120/234) were female. The majority of patients (77.8% [ n = 182/234]) received ≥2 concomitant ASMs at baseline, with the most common being carbamazepine (33.8% [ n = 79/234]). The median percent reduction in total seizure frequency per 28 days from baseline (95% confidence interval) was 55.4% (46.7%–66.7%) at Month 6. Overall, the retention rate was 57.3% ( n = 134/234) following 12 months of treatment. During the study, the overall incidence of TEAEs was 56.4% ( n = 132/234), with the most frequently reported TEAE being dizziness/vertigo (21.8% [ n = 51/234]). Serious TEAEs were experienced by 6.0% ( n = 14/234) of patients and no deaths were reported during the 12‐month treatment period. Significance Data from the AMPA study suggest that adjunctive perampanel is associated with improvement in seizure control and with good retention rates and tolerability in a real‐world clinical setting. These findings further support the use of adjunctive perampanel as a suitable treatment option for adolescent and adult patients with epilepsy. Plain Language Summary Our study looked at teenage and adult patients with epilepsy in Italy who took the study drug, called perampanel, as well as the epilepsy treatments they had already been prescribed. After 12 months, 134 out of 234 patients were still using perampanel. Patients taking perampanel had fewer seizures than they did before they started taking perampanel. Side effects occurred in 132 patients (most commonly dizziness/vertigo, irritability, and sleepiness) and caused 45 of them to withdraw from the study. Perampanel was a suitable treatment option for teenage and adult patients with epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesAnticonvulsantsSeizuresEpilepsies, PartialHumansNitrilesFemaleMaleAdultItalyAdolescentMiddle AgedYoung AdultProspective StudiesChildDrug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

adjunctive therapyanti‐seizure medicationepilepsyfocal to bilateral tonic–clonic seizureslow doseolder adults

Substanzen

perampanelNitrilesPyridonesAnticonvulsants

Autor:innen und Institutionen

  • Department of Epilepsy, IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy.
  • Department of Human Neurosciences, Epilepsy Centre, Sapienza University of Rome, Rome, Italy.
  • Institute of Neurological Science, University of Bologna, Bologna, Italy.
  • Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
  • Department of Medical and Surgical Sciences, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Department of Neuroscience, Regional Epilepsy Centre, Great Metropolitan Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy.

ORCID-Profile: Alfredo D'Aniello, Anna Teresa Giallonardo, Paolo Tinuper, Oriano Mecarelli, Umberto Aguglia, Giovanni Assenza, Antonio Gambardella, Maria Paola Canevini, Renato Scifo, Stefano Meletti, Valentina De Giorgis, Enrica Bonanni, Roberto Michelucci, Caterina Cerminara, Antonino Romeo, Federico Vigevano, Francesca Felicia Operto, Luciana Tramacere, Giancarlo Di Gennaro, Alfonso Iudice on behalf of the AMPA Study group, Leock Y Ngo, Anna Patten, Anna Lisa Gentile, Andrea Pecori

Förderung

  • Eisai s.r.l

Zitieren

APA

D'Aniello, A., Giallonardo, A. T., Tinuper, P., Mecarelli, O., Aguglia, U., Assenza, G., Gambardella, A., Canevini, M. P., Scifo, R., Meletti, S., De Giorgis, V., Bonanni, E., Michelucci, R., Cerminara, C., Romeo, A., Vigevano, F., Operto, F. F., Tramacere, L., Di Gennaro, G., …, & Goldman, S. (2025). Real‐world use of adjunctive perampanel for focal‐onset seizures in Italy: A mirroring clinical practice study of perampanel in adults and adolescents ( AMPA ). Epilepsia Open. https://doi.org/10.1002/epi4.70068

Vancouver

D'Aniello A, Giallonardo AT, Tinuper P, Mecarelli O, Aguglia U, Assenza G, et al. Real‐world use of adjunctive perampanel for focal‐onset seizures in Italy: A mirroring clinical practice study of perampanel in adults and adolescents ( AMPA ). Epilepsia Open. 2025. doi:10.1002/epi4.70068

BibTeX
@article{DAniello2025,
  author = {D'Aniello, Alfredo and Giallonardo, Anna Teresa and Tinuper, Paolo and Mecarelli, Oriano and Aguglia, Umberto and Assenza, Giovanni and Gambardella, Antonio and Canevini, Maria Paola and Scifo, Renato and Meletti, Stefano and De Giorgis, Valentina and Bonanni, Enrica and Michelucci, Roberto and Cerminara, Caterina and Romeo, Antonino and Vigevano, Federico and Operto, Francesca Felicia and Tramacere, Luciana and Di Gennaro, Giancarlo and Alfonso Iudice on behalf of the AMPA Study group, Alfonso Iudice on behalf of the AMPA Study group and Ngo, Leock Y and Patten, Anna and Gentile, Anna Lisa and Pecori, Andrea and Goldman, Samantha},
  title = {Real‐world use of adjunctive perampanel for focal‐onset seizures in Italy: A mirroring clinical practice study of perampanel in adults and adolescents ( AMPA )},
  journal = {Epilepsia Open},
  year = {2025},
  doi = {10.1002/epi4.70068}
}
Kostenlos starten →